NGL Fine-ChemNSE:NGLFINE +4.28%78 Days Inventory is 90.45 as of Mar. 2026, which is 15% below its 10-year median of 106.55. GuruFocus rates NSE:NGLFINE with a GF Score™ of 78/100 and a GF Value™ of ₹2,823.05 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 919 Drug Manufacturers companies, NGL Fine-Chem ranks better than 81.61% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). NGL Fine-Chem's Average Total Inventories for the
three
months ended in Mar. 2026 was ₹703 Mil. NGL Fine-Chem's Cost of Goods Sold for the
three
months ended in Mar. 2026 was ₹709 Mil.
Hence, NGL Fine-Chem's Days Inventory for the
three
months ended in Mar. 2026 was 90.45.
The historical rank and industry rank for NGL Fine-Chem's Days Inventory or its related term are showing as below:
NSE:NGLFINE'
s Days Inventory Range Over the Past 10 Years
Min: 80.85 Med: 106.55 Max: 131.86
Current: 95.81
During the past 13 years, NGL Fine-Chem's highest Days Inventory was 131.86. The lowest was 80.85. And the median was 106.55.
NSE:NGLFINE's Days Inventory is ranked better than 81.61% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:NGLFINE: 95.81
NGL Fine-Chem's Days Inventory
declined
from Mar. 2025 (97.87) to Mar. 2026 (90.45).
Inventory Turnover measures how fast the company turns over its inventory within a year.
NGL Fine-Chem's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.01.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
NGL Fine-Chem's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.47.
NGL Fine-Chem (NSE:NGLFINE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
NGL Fine-Chem's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
NGL Fine-Chem's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
NGL Fine-Chem Days Inventory Related Terms
NGL Fine-Chem Days Inventory Historical Data
* Premium members only.
The historical data trend for NGL Fine-Chem's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NGLFINE vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, NGL Fine-Chem's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NGL Fine-Chem Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's Days Inventory distribution charts can be found below:
* The bar in red indicates where NGL Fine-Chem's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGL Fine-Chem (NSE:NGLFINE) has a Days Inventory of 90.45 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on NGL Fine-Chem and its competitors. This is 15% below median its historical median of 106.55. Over the past decade, NGL Fine-Chem's Days Inventory has ranged from 80.85 to 131.86. According to the industry distribution chart, NGL Fine-Chem ranks #169 out of 919 companies in the Drug Manufacturers industry, placing it in the top 18.4%.
Is NGL Fine-Chem's Days Inventory too high?
NGL Fine-Chem's current Days Inventory of 90.45 is 15% below median its 10-year median of 106.55. Over the past 10 years, this metric has ranged from a low of 80.85 to a high of 131.86. The Drug Manufacturers industry median Days Inventory is 164.48. NGL Fine-Chem's value of 90.45 is 45% below this industry median. Based on the distribution chart, NGL Fine-Chem ranks #169 out of 919 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, NGL Fine-Chem has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NGL Fine-Chem's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, NGL Fine-Chem ranks #169 out of 919 companies for Days Inventory. This places NGL Fine-Chem in the top 18% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. NGL Fine-Chem's value of 90.45 is 45% below this benchmark. Historically, NGL Fine-Chem's own Days Inventory has ranged from 80.85 to 131.86 over the past decade. While the company's 10-year median is 106.55 vs. the industry median of 164.48, NGL Fine-Chem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NGL Fine-Chem's current Days Inventory of 90.45 is 45% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on NGL Fine-Chem and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NGL Fine-Chem's current Days Inventory is 90.45, which is 15% below median its own 10-year median of 106.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NGL Fine-Chem stock overvalued right now?
Based on GuruFocus' analysis, NGL Fine-Chem (NSE:NGLFINE) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,823.05, compared to a current price of ₹3,224.60 — trading 14.2% above its estimated fair value. The current Days Inventory is 90.45, which is 15% below median its 10-year median of 106.55 and 45% below the Drug Manufacturers industry median of 164.48. NGL Fine-Chem's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For NGL Fine-Chem (NSE:NGLFINE), the current Days Inventory is 90.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NGL Fine-Chem (NSE:NGLFINE) Overvalued in 2026?
Based on GuruFocus' analysis, NGL Fine-Chem stock appears to be overvalued.
The current stock price of ₹3,224.60 is trading 14.2% above its estimated GF Value™ of ₹2,823.05.
GuruFocus considers NGL Fine-Chem to be Modestly Overvalued.
Key valuation signals for NSE:NGLFINE:
Days Inventory: 90.45 (15% below median its 10-year median of 106.55)
GF Value™: ₹2,823.05 vs. price of ₹3,224.60 (14.2% above fair value)
Industry Position: 45% below the Drug Manufacturers median (#169 of 919)
No single metric tells the full story. See the NSE:NGLFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
78GF Score
Get the complete analysis for NSE:NGLFINE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NGLFINE has been successfully added to your 
